Madrigal Pharmaceuticals Inc (NASDAQ:MDGL)
| 78.34 Delayed Data As of 3:59pm ET |  +0.93 / +1.20%Today’s Change | 76.03 Today|||52-Week Range 142.62 | -29.53% Year-to-Date |
Latest MDGL News | Press Releases
No recent news for Madrigal Pharmaceuticals Inc.
Today’s Trading
| Previous close | 77.41 |
| Today’s open | 77.45 |
| Day’s range | 76.07 - 78.45 |
| Volume | 2,165 |
| Average volume (3 months) | 121,582 |
| Market cap | $1.4B |
Data as of 3:59pm ET, 10/22/2021
Growth & Valuation
| Earnings growth (last year) | -140.10% |
| Earnings growth (this year) | -14.11% |
| Earnings growth (next 5 years) | 0.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 5.55 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ZEALZealand Pharma A/S | +0.60 | +1.88% |
| MGNXMacroGenics Inc | -0.33 | -1.70% |
| ARCTArcturus Therapeutic... | -0.12 | -0.27% |
| KURAKura Oncology Inc | -0.01 | -0.06% |
Data as of 4:00pm ET, 10/22/2021
Financials
| Next reporting date | November 11, 2021 |
| EPS forecast (this quarter) | -$3.87 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$202.2M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters West Conshohocken, Pennsylvania |
Forecasts
